CD8A and neoplasm: The extent of therapy-induced tumor necrosis was linearly related to the natural logarithm of the ratio of tumor-infiltrating CD8+ effector T cells to Treg cells in posttreatment biopsies of metastatic lesions, indicating that ipilimumab can modulate the balance of effector T cells and Treg cells [34].